Mylan Rolls Out Semglee Insulin In Australia

Australia
Australian diabetics now how another treatment option with the launch of Mylan's Semglee insulin glargine biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products